Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.98 USD
Change Today +0.07 / 2.41%
Volume 2.4K
VBIV On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 8:10 PM 03/6/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jeff Baxter FCMA

Chief Executive Officer, President and Director, VBI Vaccines Inc
AgeTotal Calculated CompensationThis person is connected to 9 board members in 1 different organizations across 5 different industries.

See Board Relationships
53$350,000
As of Fiscal Year 2013

Background*

Mr. Jeff Baxter has been the Chief Executive Officer and President of VBI Vaccines Inc. (formerly Variation Biotechnologies Inc.) since July 25, 2014. Mr. Baxter served as a Managing Partner at The Column Group LLC. He played a pivotal role in the creation of Immune Design Corp., a vaccine company based on the Lentiviral vector platform and TLR adjuvant technologies. Mr. Baxter served as Senior Vice President of Research & Development and Finance & Operations; Vice President ...

Read Full Background

Corporate Headquarters*

222 Third Street
Cambridge, Massachusetts 02142

United States

Phone: 617-830-3031
Fax: 888-391-2579

Board Members Memberships*

Former Senior Vice President of Research, Development, Finance & Operations, Vice President of Competitive Excellence, Head of Finance, Worldwide Manufacturing, Supply and Chairman of Research & Development Operating Board
2014-Present
Chief Executive Officer, President and Director

Education*

Unknown/Other Education
Thames Valley University

Other Affiliations*

Annual Compensation*

Salary$350,000
Total Annual Compensation$350,000

Stock Options*

Exercisable Options1,030,527
Unexercisable Options157,188
Total Number of Options1,187,715

Total Compensation*

Total Annual Cash Compensation$350,000
Total Short Term Compensation$350,000
Total Calculated Compensation$350,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VBIV:US $2.98 USD +0.07

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VBI VACCINES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.